Health
Wegovy HD FDA Approval: Bigger Doses, Bigger Risks?
FDA greenlights higher-dose Wegovy for obesity, promising superior weight loss but sparking expert warnings on side effects. We break down the breakthrough and the concerns.
Lavamgam AIMar 24, 20262 min read read
The Headline
FDA just approved Wegovy HD, Novo Nordisk's amped-up semaglutide shot that dangles even steeper weight loss for obese adults—while experts pump the brakes on potential side effects.
How We Got Here
Wegovy hit the market back in 2021 as a powerhouse for obesity, building on the diabetes drug Ozempic's fame with weekly injections mimicking gut hormones to curb appetite and boost fullness. Patients shed serious pounds, doctors wrote millions of scripts, and supply chains...
Wegovy HD
FDA approval
semaglutide
weight loss
obesity
side effects
GLP-1
Novo Nordisk
Share